I agree that this site is using cookies. You can find further informations here.
X
Cesaretti, Marina
20  results:
Search for persons X
?
1

IELSG30 phase 2 trial: intravenous and intrathecal CNS prop..:

Conconi, Annarita ; Chiappella, Annalisa ; Ferreri, Andrés J. M....
Blood Advances.  8 (2024)  6 - p. 1541-1549 , 2024
Link: https://doi.org/10.1182/..
 
?
2

Incidence and outcomes of rare T cell lymphomas from the T ..:

Foss, Francine M. ; Horwitz, Steven M. ; Civallero, Monica...
American Journal of Hematology.  95 (2019)  2 - p. 151-155 , 2019
Link: https://doi.org/10.1002/..
 
?
3

Efficacy of bendamustine and rituximab in splenic marginal ..:

Iannitto, Emilio ; Bellei, Monica ; Amorim, Sandy...
British Journal of Haematology.  183 (2018)  5 - p. 755-765 , 2018
Link: https://doi.org/10.1111/..
 
?
4

Dismal outcome of t‐cell lymphoma patients failing first‐li..:

Biasoli, Irene ; Cesaretti, Marina ; Bellei, Monica...
Hematological Oncology.  33 (2014)  3 - p. 147-151 , 2014
Link: https://doi.org/10.1002/..
 
?
5

EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MED..:

Federico, Massimo ; El Mistiri, Mufid ; Macchia, Matteo..
Mediterranean Journal of Hematology and Infectious Diseases.  6 (2014)  1 - p. e2014048 , 2014
Link: https://doi.org/10.4084/..
 
?
6

Risk factors for impaired gonadal function in female Hodgki..:

Falorio, Simona ; Biasoli, Irene ; Luminari, Stefano...
Hematological Oncology.  31 (2012)  2 - p. 72-78 , 2012
Link: https://doi.org/10.1002/..
 
?
7

Incidence, clinical characteristics and survival of maligna..:

Luminari, Stefano ; Cesaretti, Marina ; Rashid, Ivan...
Hematological Oncology.  25 (2007)  4 - p. 189-197 , 2007
Link: https://doi.org/10.1002/..
 
?
8

Purification and Characterization of Heparin from the Itali..:

Luppi, Elisa ; Cesaretti, Marina ; Volpi, Nicola
Biomacromolecules.  6 (2005)  3 - p. 1672-1678 , 2005
Link: https://doi.org/10.1021/..
 
?
9

Incidence and outcomes of rare T cell lymphomas from the T ..:

Foss, Francine M ; Horwitz, Steven M ; Civallero, Mónica...
American Journal of Hematology 2020;95:151–155..  , 2020
Link: https://doi.org/10.1002/..
 
?
10

Early progression as a predictor of survival in marginal zo..:

Luminari Stefano ; Merli Michele ; Rattotti Sara...
info:eu-repo/semantics/altIdentifier/pmid/31292118.  , 2019
Link: http://hdl.handle.net/11..
 
?
11

Incidence and outcomes of rare T cell lymphomas from the T ..:

Foss, Francine M ; Horwitz, Steven M ; Civallero, Monica...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025136/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
12

Safety and efficacy of lenalidomide in combination with rit..:

Sacchi, Stefano ; Marcheselli, Raffaella ; Bari, Alessia...
info:eu-repo/semantics/altIdentifier/pmid/26858355.  , 2016
Link: http://hdl.handle.net/11..
 
?
13

Epidemiological overview of Hodgkin lymphoma across the Med..:

Salati, Massimiliano ; CESARETTI, Marina ; FEDERICO, Massimo..
info:eu-repo/semantics/altIdentifier/pmid/25045456.  , 2014
Link: http://hdl.handle.net/11..
 
?
14

EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MED..:

Massimiliano Salati ; Marina Cesaretti ; Matteo Macchia..
http://www.mjhid.org/index.php/mjhid/article/view/1371.  , 2014
Link: https://doi.org/10.4084/..
 
?
15

Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir..:

Tiseo, Giusy ; Barbieri, Chiara ; Galfo, Valentina...
Infectious Diseases and Therapy.  12 (2022)  1 - p. 257-271 , 2022
Link: https://doi.org/10.1007/..
 
1-15